chr9-93185079-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006648.4(WNK2):āc.150C>Gā(p.Asp50Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000608 in 1,315,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006648.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WNK2 | NM_006648.4 | c.150C>G | p.Asp50Glu | missense_variant | 2/30 | ENST00000427277.7 | NP_006639.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WNK2 | ENST00000427277.7 | c.150C>G | p.Asp50Glu | missense_variant | 2/30 | 5 | NM_006648.4 | ENSP00000411181.4 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150918Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000411 AC: 2AN: 48684Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 29900
GnomAD4 exome AF: 0.00000601 AC: 7AN: 1164134Hom.: 0 Cov.: 31 AF XY: 0.00000528 AC XY: 3AN XY: 568480
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150918Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73702
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2024 | The c.150C>G (p.D50E) alteration is located in exon 1 (coding exon 1) of the WNK2 gene. This alteration results from a C to G substitution at nucleotide position 150, causing the aspartic acid (D) at amino acid position 50 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at